RC
Schedule 13G filing
RA CAPITAL MANAGEMENT, L.P. disclosed a 9.9% stake in Corbus Pharmaceuticals Holdings, Inc. (CRBP)
RA CAPITAL MANAGEMENT, L.P. reported owning 9.9% of Corbus Pharmaceuticals Holdings, Inc. (CRBP) (1,914,788 shares) in a Schedule 13G filed Sep 30, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Sep 30, 2026
- Source
- Schedule 13G
More CRBP insider and Congress trades
From a public Schedule 13G, linked above. Not investment advice, and not a recommendation to buy or sell.